GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » Interest and Commission Paid

Senhwa Biosciences (ROCO:6492) Interest and Commission Paid


View and export this data going back to 2014. Start your Free Trial

What is Senhwa Biosciences Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Senhwa Biosciences Business Description

Traded in Other Exchanges
N/A
Address
Peihsin Road, 10th Floor, No. 225, Section 3, Hsintien District, New Taipei, TWN, 23143
Senhwa Biosciences Inc is engaged in the development of new drugs and special pharmaceutical ingredients focusing on human efficacy. The company's product pipeline includes Pidnarulex (CX-5461), Silmitasertib (CX-4945), and Silmitasertib (for Moderate Covid-19). All of its revenue comes from Taiwan.